- Home
- SDHC vs INO Comparison
SDHC vs INO Comparison
Compare SDHC & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SDHC | INO |
|---|---|---|
| Founded | 2008 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.3M | 114.0M |
| IPO Year | 2023 | 1999 |
Fundamental Metrics
Financial Performance| Metric | SDHC | INO |
|---|---|---|
| Price | $13.16 | $1.25 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $14.60 | $6.75 |
| AVG Volume (30 Days) | 77.6K | ★ 2.0M |
| Earning Date | 04-29-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.18 |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $971,116,000.00 | $42,220,086.00 |
| Revenue This Year | $4.21 | $20,156.19 |
| Revenue Next Year | $11.07 | $421.95 |
| P/E Ratio | $216.67 | ★ N/A |
| Revenue Growth | N/A | ★ 19.37 |
| 52 Week Low | $11.13 | $1.03 |
| 52 Week High | $23.50 | $2.86 |
Technical Indicators
Market Signals| Indicator | SDHC | INO |
|---|---|---|
| Relative Strength Index (RSI) | 43.71 | 51.68 |
| Support Level | $11.18 | $1.03 |
| Resistance Level | $15.45 | $1.78 |
| Average True Range (ATR) | 0.89 | 0.05 |
| MACD | -0.12 | 0.03 |
| Stochastic Oscillator | 18.66 | 93.75 |
Price Performance
Historical ComparisonAbout SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corpis a builder of single-family homes in communities in certain markets in the southeastern and southern United States. The Company's homes and communities are targeted to first-time and empty-nest homebuyers. The Company currently operates in metropolitan Atlanta, Birmingham, Chattanooga, Central Georgia, Charlotte, Dallas-Fort Worth, Greenville, Alabama Gulf Coast, Huntsville, Nashville, Raleigh and Houston. Its operations are currently organized into ten geographical divisions which comprise two reportable segments. Its Southeast segment consists of its Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of its Alabama, Dallas-Fort Worth, Houston, Nashville, and Alabama Gulf Coast divisions.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.